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both hypertensive diabetic group and hypertensive group was
signiﬁcantly decreased compared to that in the normal group
(P<0.05). While the mean plasma level of sVEGFR2 in hypertensive
diabetic group were signiﬁcantly decreased compared to the hyper-
tensive group (P<0.05). And the mean plasma level of visfatin in both
hypertensive diabetic group and only hypertensive group was
signiﬁcantly increased compared to that in the normal group
(P<0.05), and more increased in hypertensive diabetic patients.
(P<0.05). Moreover, there was a signiﬁcantly negative correla-
tion between sVEGFR2 and visfatin in the whole study population
(r¼ -0.497, P<0.01).
CONCLUSIONS Soluble VEGFR2 expression is decreased in both hy-
pertensive and hypertensive diabetic patients, and more decreased in
hypertensive diabetic patients. This study indicates that decreased
sVEGFR2 level may be associated with to the increase of visfatin.
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OBJECTIVES The main feature of postprandial hypotension(PPH) is
the blood pressure being lower compared with that before a meal, and
it may lead to syncope, fall, dizziness, nausea, visual disturbance,
cardiovascular events, brain stroke and even death when it has a
sharply fall. This study focuses on patients with coronary heart dis-
ease to explore the prevalence of PPH among patients with coronary
heart disease and relevant risk factors.
METHODS Choose 289 patients with coronary heart disease, age
range: 24-90, average age: 62.0012.22 years old. All patients are
divided into different groups on the basis of age and different groups
by basic systolic blood pressure level. The blood pressure of patients
need to be measured before breakfast, lunch and dinner as well as 30,
60, 90 and 120min after meals.
RESULTS The systolic blood pressure of a total of 50 cases of 289
patients drops 20mmHg, and the prevalence of PPH is 17.30%. There
are 28 males (9.69%) and 22 females (7.61%) and the prevalence dif-
ference of PPH has no statistical signiﬁcance (P>0.05). The difference
of PPH among patients with diabetes, cerebrovascular disease, hy-
pertension, hyperlipemia has no statistical signiﬁcance (P>0.05).
Among patients with taking medications which affect the blood
pressure the prevalence is 15.57%; and the patients without taking
medications which affect the blood pressure have PPH along with
incidence is 1.73%; the difference of PPH has statistical signiﬁcance
(P<0.05). The prevalence of PPH for different age groups has no sta-
tistical signiﬁcance (P>0.05). The prevalence of PPH of breakfast,
lunch and dinner is 8.10%, 5.19% and 9.00%, the prevalence of
different mealtime has no statistical signiﬁcance (P>0.05). Taking
medications which affect the blood pressure and basic blood pressure
level are risk factors for PPH and corresponding OR is 4.05(95%CI 1.52-
10.79) and 1.84 (95%CI 1.37-2.49). But in the hospital, there is no
statistical difference in the adverse cardiovascular events between the
patients with PPH and other patients.
CONCLUSIONS The prevalence of PPH for patients with coronary
heart disease is 17.30%. There is no oblivious relevance between PPH
and gender, age, body position during meal and whether patients
have high blood pressure, hyperlipidemia, diabetes and cerebral
vascular disease. Taking medications which affect the blood pressure
and basic blood pressure level are risk factors for PPH.
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OBJECTIVES Since renal sympathetic denervation (RDN) has been
recently shown to be an attractive new method in treating the patient
with resistant hypertension, we decided to proceed with RDN after
discussion with the patient.
METHODS The dosage of Iohexol contrast was 75 ml. The duration of
procedure was 55 minutes. The number of ablation point was 6 onboth sides. The left renal artery underwent ablation using routine
method.The duration of procedure was 55 minutes. The number of
ablation point was 6 on both sides. The left renal artery underwent
ablation using routine method.
RESULTS In this case report, we have successfully treated a patient
with resistant hypertension, who underwent renal artery stent
implantation.
CONCLUSIONS This is in accordance with previous reports that RDN
is well tolerated and a safe procedure. To best of our knowledge, there
are very few studies that RDN procedure was conducted in patient
who underwent renal artery stent implantation. Out ﬁnding suggest
that continued research into the RDN for the treatment of resistant
hypertension in selected patients is of interest.
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OBJECTIVES To investigate the effects of irbesartan combined with
diltiazem on the endothelium-dependent vasodilatation and cardio-
vascular protection in Chinese essential hypertensives.
METHODS 142Chinese hypertensives were enrolled in this study.
Hypertensive patients were divided into 3 groups: Irbesartan treated
(150 mg/day, n¼42), diltiazem treated (90 mg/day, n¼50), and com-
bined therapy ( Irbesartan 150 mg/dayþ diltiazem 90 mg/day, n¼50).
26 normotensives without cardiovascular risks served as control
group. Flow-mediated dilatation (FMD) induced by reactive hyper-
emia was used to determine endothelium-dependent dilatation (EDD)
and nitroglycerin-mediated dilatation (NMD) induced by nitroglycerin
was used to determine endothelium-independent dilatation (EID)
respectively in brachial arteries using high-resolution vascular ultra-
sound. Left ventricular mass index (LVMI) was evaluated by echo-
cardiography, Blood pressure (BP) and ﬁbrinogen (Fg) was monitored
at baseline and after treatment. All subjects were followed up for 1
year.
RESULTS BP, LVMI, Fg were higher and FMD and NMD were lower in
hypertensive patients than those in normotensive controls at base-
line. After 1- year treatment, there was a signiﬁcant increase of FMD in
combined therapy group compared with irbesartan treated group and
diltiazem treated group [(8.313.09)% vs (10.683.51)%, P<0.05], af-
ter stratiﬁcation of age, while there was no signiﬁcant difference in
NMD after therapy among three groups (P>0.05). FMD decreased
obviously with the increase of age, which turned out to be not so
obviously after irbesartan combined with diltiazem treatment
compared with normotensive controls. In addition, Fg decreased
signiﬁcantly after treatment in combined therapy group [(3.570.78)
g/L vs (3.090.83) g/L, P<0.05]. LVMI also reduced obviously after
irbesartan alone and combined therapy treatment and the reduction
of LVMI was much more remarkable in combined therapy group than
in irbesartan group [irbesartan group: (98.9318.23) g/m2 vs
(92.8214.48) g/m2, P<0.05; combined therapy group: (97.3216.93)
g/m2 vs (88.7016.21) g/m2, P<0.01].
CONCLUSIONS Irbesartan combined with diltiazem therapy could
improve the endothelium dependent vasodilatation in essential hy-
pertensives signiﬁcantly, regardless of age, further reduced LVMI and
Fg more obviously compared with monotherapy. Therefore, irbe-
sartan combined with diltiazem might be more beneﬁcial for reducing
the cardiovascular complications in hypertensives and presented su-
perior cardiovascular protection than monotherapy.
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OBJECTIVES The study aimed to explore possible factors associated
with morning blood pressure surge, underlying pathophysiological
mechanisms and the target of drug therapy in young and middle–aged
essential hypertensive patients.
METHODS The objects included in this study were 160 young and
middle–aged (younger than 60 years) essential hypertensive patients
who were in the ward of hypertension in Peking University People’s
Hospital from November 1,2011 to January 31,2015. All the objects
